Related Experiment Video
Updated: Jul 25, 2026

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
Published on: July 20, 2016
Poly(ADP-ribosyl)ation in relation to cancer and autoimmune disease
M Masutani1, H Nakagama, T Sugimura
1Biochemistry Division, National Cancer Center Research Institute, 1-1 Tsukiji 5-chome, Tokyo 104-0045, Japan. mmasutan@gan2.res.ncc.go.jp
Abstract:
Carcinogenesis involves multiple steps and pathways with functional alterations in a variety of genes. There is accumulating evidence that a deficiency of poly(ADP-ribose) polymerase (PARP)-1 leads to DNA repair defects, genomic instability, failure of induction of cell death and modulation of gene transcription. PARP-1 also supports the growth of tumor cells in certain situations. Genetic analyses of the PARP-1 gene have demonstrated alterations in neoplasms, and a mutation affecting the conserved amino acid E251 in germ cell tumors, as well as an association of a single-nucleotide polymorphism V762A with risk of prostate cancer. Recent development of a selective inhibitor of poly(ADP-ribose) glycohydrolase (PARG), the enzyme primarily responsible for degradation of poly(ADP-ribose), and PARG-deficient animals should facilitate studies of the relationship of poly(ADP-ribose) with carcinogenesis. Inhibitors of PARP have also suggested roles in the pathogenesis of autoimmune disease, and a promoter haplotype of PARP-1 confers a higher risk of rheumatoid arthritis. Further analysis of PARP-1, PARG and other PARP family genes should extend our understanding of the pathogenesis of cancer and autoimmune diseases. Furthermore, there is potential for sensitization to chemo- and radiation therapy of cancers as well as the treatment of autoimmune disease with development of stronger PARP inhibitors.
Insights
Poly(ADP-ribose) polymerase (PARP)-1 deficiency causes DNA repair issues and genomic instability, impacting cancer and autoimmune disease development. Stronger PARP inhibitors may improve cancer therapy and treat autoimmune conditions.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- Carcinogenesis involves complex genetic alterations.
- Poly(ADP-ribose) polymerase (PARP)-1 deficiency is linked to DNA repair defects, genomic instability, and altered gene transcription.
- PARP-1 plays a role in tumor cell growth and is implicated in neoplasms and cancer risk.
Purpose of the Study:
- To investigate the role of PARP-1 and related enzymes in carcinogenesis and autoimmune diseases.
- To explore the therapeutic potential of PARP inhibitors in cancer and autoimmune conditions.
Main Methods:
- Genetic analyses of the PARP-1 gene in neoplasms.
- Investigating the impact of poly(ADP-ribose) and its metabolism using PARG inhibitors and deficient animals.
- Examining the association of PARP-1 genetic variations with cancer risk and autoimmune disease susceptibility.
Main Results:
- PARP-1 deficiency leads to DNA repair defects, genomic instability, and affects cell death and gene transcription.
- Alterations in the PARP-1 gene, including mutations and polymorphisms, are found in various cancers.
- PARP-1 genetic variations are associated with increased risk for prostate cancer and rheumatoid arthritis.
Conclusions:
- Further research on PARP-1, PARG, and other PARP family members is crucial for understanding cancer and autoimmune disease pathogenesis.
- Development of potent PARP inhibitors holds promise for enhancing chemo- and radiation therapy efficacy in cancer and treating autoimmune diseases.
More Related Videos
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune system...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Biosynthesis of Nucleic Acids

